Study to Evaluate the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to FluzoneÂ® Quadrivalent in Children 6 to 35 Months of Age